IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Imunon, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 11, 2026
$0.98−0.04 (-3.43%)
Close on Oct 19, 2026
- Market cap
- $4.95M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jul 25, 2025 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 31, 2022(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 1, 2022 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Aug 14, 2017(first seen in filings) | 1-for-25.5 reverse | Earlier per-share figures multiplied by 25.5 |
| May 30, 2017 | 1-for-14 reverse | Earlier per-share figures multiplied by 14 |
| Oct 28, 2013 | 1-for-4.5 reverse | Earlier per-share figures multiplied by 4.5 |
| Feb 28, 2006 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |